Revised: 23 April 2015
Committees
Summary of Recommendations from the 101st meeting of the Medicines Assessment
Advisory Committee held in the Rydges Wellington,
75 Featherston Street, Pipitea, Wellington 6011on Tuesday 10 March 2015
at 9:30 am
Present:
Associate Professor Richard Robson (Chair)
Associate Professor Paul Fawcett
Dr Rupert Handy
Dr Mark Jeffery
Dr Damian Pethica
Dr AbiGail Rayner
Mrs Catherine Ryan
Dr Paul Tomlinson
Dr David Woolner
Ms Andrea Kerridge (Secretary)
In Attendance (from Medsafe):
Mrs Frances Barton (Team Leader, Medicines Assessment, Product
Regulation)
Dr Alex Bolotovski (Senior Medical Advisor, Clinical Risk Management)
Dr Adrian Britt (Senior Advisor Science, Medicines Assessment, Product Regulation)
Ms Alyssa Currie (Team Leader, Committee and Support Services, Product Regulation)
Dr Carole Firth (Team Leader, Medicines Assessment, Product Regulation)
Dr Richard Jaine, (Principal Clinical Advisor)
Ms Sarah Reader (Manager, Product Regulation)
Dr Debbie Scarlett (Advisor Science, Medicines Assessment, Product Regulation)
Observers (for specific agenda items only)
Te Arai BioFarma Limited
Apologies:
Associate Professor Christopher Frampton
Professor Paul Glue
Dr Deborah Greig
6 |
Applications for consent to distribute a new medicine under section 20 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2)) |
6.1 |
Tresivac MMR vaccine, powder for injection with diluent (TT50-9138)
|
